Author Steinacker, Petra

1 to 20 of 28 Items

2022 | Journal Article | Research Paper
Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion
Oeckl, P.; Anderl-Straub, S.; Von Arnim, C. A. F.; Baldeiras, I.; Diehl-Schmid, J.; Grimmer, T. & Halbgebauer, S. et al. (2022)
Journal of Neurology, Neurosurgery & Psychiatry,. DOI: https://doi.org/10.1136/jnnp-2021-328547
Details DOI PMID PMC

2022 | Journal Article |
Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer’s and other neurodegenerative diseases
Halbgebauer, S.; Steinacker, P.; Riedel, D.; Oeckl, P.; Anderl-Straub, S.; Lombardi, J. & von Arnim, C. A. F. et al. (2022)
Alzheimer's Research & Therapy, 14(1). DOI: https://doi.org/10.1186/s13195-022-01122-4
Details DOI

2021 | Journal Article
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS
Halbgebauer, S.; Steinacker, P.; Verde, F.; Weishaupt, J.; Oeckl, P.; von Arnim, C. & Dorst, J. et al. (2021)
Journal of Neurology, Neurosurgery & Psychiatry, 93(1) pp. 68-74. DOI: https://doi.org/10.1136/jnnp-2021-327129
Details DOI

2021 | Journal Article |
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Freigang, M.; Steinacker, P.; Wurster, C. D.; Schreiber-Katz, O.; Osmanovic, A.; Petri, S. & Koch, J. C. et al. (2021)
Orphanet Journal of Rare Diseases, 16(1) art. 330. DOI: https://doi.org/10.1186/s13023-021-01961-8
Details DOI

2014 | Journal Article
Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases
Feneberg, E.; Steinacker, P.; Lehnert, S.; Schneider, A.; Walther, P.; Thal, D. R. & Linsenmeier, M. et al. (2014)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15(5-6) pp. 351-356. DOI: https://doi.org/10.3109/21678421.2014.905606
Details DOI PMID PMC WoS

2012 | Journal Article |
Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson’s Disease Dementia
Jesse, S.; Lehnert, S.; Jahn, O.; Parnetti, L.; Soininen, H.; Herukka, S.-K. & Steinacker, P. et al. (2012)
PLoS ONE, 7(11) art. e48783. DOI: https://doi.org/10.1371/journal.pone.0048783
Details DOI

2012 | Journal Article | Research Paper
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS
Otto, M.; Bowser, R.; Turner, M.; Berry, J.; Brettschneider, J.; Connor, J. & Costa, J. et al. (2012)
Amyotrophic Lateral Sclerosis, 13(1) pp. 1-10. DOI: https://doi.org/10.3109/17482968.2011.627589
Details DOI PMID PMC

2011 | Journal Article |
Different CSF beta-amyloid processing in Alzheimer's and Creutzfeldt-Jakob disease (vol 118, pg 691, 2011)
Mollenhauer, B.; Esselmann, H.; Roeber, S.; Schulz-Schaeffer, W. J.; Trenkwalder, C.; Bibl, M. & Steinacker, P. et al. (2011)
Journal of Neural Transmission, 118(8) pp. 1261-1262. DOI: https://doi.org/10.1007/s00702-011-0669-7
Details DOI WoS

2011 | Journal Article |
Different CSF beta-amyloid processing in Alzheimer's and Creutzfeldt-Jakob disease
Mollenhauer, B.; Esselmann, H.; Roeber, S.; Schulz-Schaeffer, W. J.; Trenkwalder, C.; Bibl, M. & Steinacker, P. et al. (2011)
Journal of Neural Transmission, 118(5) pp. 691-697. DOI: https://doi.org/10.1007/s00702-010-0543-z
Details DOI PMID PMC WoS

2010 | Journal Article | Research Paper
Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis
Steinacker, P.; Hawlik, A.; Lehnert, S.; Jahn, O. ; Meier, S.; Görz, E. & Braunstein, K. E. et al. (2010)
The American Journal of Pathology, 176(3) pp. 1409-1420. DOI: https://doi.org/10.2353/ajpath.2010.090355
Details DOI PMID PMC

2010 | Journal Article |
A Proteomic Approach for the Diagnosis of Bacterial Meningitis
Jesse, S.; Steinacker, P.; Lehnert, S.; Sdzuj, M.; Cepek, L.; Tumani, H. & Jahn, O. et al. (2010)
PLoS One, 5(4) art. e10079. DOI: https://doi.org/10.1371/journal.pone.0010079
Details DOI PMID PMC WoS

2009 | Journal Article |
Proteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage.
Linker, R. A.; Brechlin, P.; Jesse, S.; Steinacker, P.; Lee, D. H.; Asif, A. R. & Jahn, O. et al. (2009)
PLoS One, 4(10) art. e7624. DOI: https://doi.org/10.1371/journal.pone.0007624
Details DOI PMID PMC

2008 | Journal Article
Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease
Brechlin, P.; Jahn, O. ; Steinacker, P.; Cepek, L.; Kratzin, H.; Lehnert, S. & Jesse, S. et al. (2008)
Proteomics, 8(20) pp. 4357-4366. DOI: https://doi.org/10.1002/pmic.200800375
Details DOI PMID PMC WoS

2007 | Journal Article
Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: Marker candidates for dementia with Lewy bodies
Mollenhauer, B.; Steinacker, P.; Bahn, E.; Bibl, M.; Brechlin, P.; Schlossmacher, M. G. & Locascio, J. J. et al. (2007)
Neurodegenerative Diseases, 4(5) pp. 366-375. DOI: https://doi.org/10.1159/000105157
Details DOI PMID PMC WoS

2007 | Journal Article
Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
Cepek, L.; Brechlin, P.; Steinacker, P.; Mollenhauer, B.; Klingebiel, E.; Bibl, M. & Kretzschmar, H. A. et al. (2007)
Dementia and Geriatric Cognitive Disorders, 23(1) pp. 22-28. DOI: https://doi.org/10.1159/000096589
Details DOI PMID PMC WoS

2007 | Journal Article
Tauopathies and synucleinopathies: Do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?
Mollenhauer, B.; Bibl, M.; Esselmann, H.; Steinacker, P.; Trenkwalder, C.; Wiltfang, J. & Otto, M. (2007)
Journal of Neural Transmission, 114(7) pp. 919-927. DOI: https://doi.org/10.1007/s00702-007-0629-4
Details DOI PMID PMC WoS

2006 | Journal Article
Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies
Mollenhauer, B.; Bibl, M.; Wiltfang, J.; Steinacker, P.; Ciesielczyk, B.; Neubert, K. & Trenkwalder, C. et al. (2006)
Clinical Chemistry and Laboratory Medicine (CCLM), 44(2) pp. 192-195. DOI: https://doi.org/10.1515/CCLM.2006.035
Details DOI PMID PMC WoS

2006 | Journal Article
Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia
Mollenhauer, B.; Trenkwalder, C.; von Ahsen, N.; Bibl, M.; Steinacker, P.; Brechlin, P. & Schindehuette, J. et al. (2006)
Dementia and Geriatric Cognitive Disorders, 22(3) pp. 200-208. DOI: https://doi.org/10.1159/000094871
Details DOI PMID PMC WoS

2006 | Journal Article | Letter Note
Selective reduction of amyloid beta 42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation
Mollenhauer, B.; Bibl, M.; Esselmann, H.; Steinacker, P.; Trenkwalder, C.; Brechlin, P. & Wiltfang, J. et al. (2006)
Journal of Neurology Neurosurgery & Psychiatry, 77(10) pp. 1201-1203. DOI: https://doi.org/10.1136/jnnp.2005.084673
Details DOI PMID PMC WoS

Göttingen All

issue date

ASC DESC

10 20 50 100